IP Library Granted Patent US 8,449,872
Granted Patent B2
US 8,449,872 · App. 13/119,215 · Granted May 28, 2013

Polymer conjugates of nesiritide peptides

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,449,872
App. No.
13/119,215
Granted
May 28, 2013
Kind
B2
Abstract

The invention provides peptides that are chemically modified by covalent attachment of a water-soluble oligomer. A conjugate of the invention, when administered by any of a number of administration routes, exhibits characteristics that are different from the characteristics of peptide not attached to the water-soluble oligomer.

Claims (10)

1. A conjugate comprising a residue of a nesiritide moiety wherein the conjugate has the structure:

wherein each n is an integer from 10 to 1800.

2. The conjugate of claim 1 , wherein each CH 3 O—(CH 2 CH 2 O) n CH 2 CH 2 — has a weight-average molecular weight in a range of from about 2000 Daltons to about 50,000 Daltons.

3. The conjugate of claim 2 , wherein each CH 3 O—(CH 2 CH 2 O) n CH 2 CH 2 — has a weight-average molecular weight in a range of from about 5000 Daltons to about 40,000 Daltons.

4. The conjugate of claim 1 , wherein the nesiritide moiety is attached at an amino-terminal amino acid of the nesiritide moiety.

5. The conjugate of claim 1 , wherein the nesiritide moiety is attached at an epsilon amino group of an internal lysine amino acid of the nesiritide moiety.

6. A pharmaceutical composition comprising a conjugate of claim 1 and a pharmaceutically acceptable excipient.

7. A method for making a conjugate of claim 1 comprising contacting, under conjugation conditions, a nesiritide moiety with a polymeric reagent bearing a functional group.

8. The conjugate of claim 1 , wherein the nesiritide moiety has the amino acid sequence of SEQ ID NO: 1.

9. The conjugate of claim 2 , wherein each CH 3 O—(CH 2 CH 2 O) n CH 2 CH 2 — has a weight-average molecular weight of about 20,000 Daltons.

Assignments (5)
RELEASE OF SECURITY INTEREST Recorded Apr 17, 2020
From: TC LENDING, LLC, AS COLLATERAL AGENT
To: NEKTAR THERAPEUTICS
Reel/Frame 053180/0009 →
RELEASE OF SECURITY INTEREST RECORDED AT REEL 28571, FRAME 0141 Recorded Oct 14, 2015
From: WELLS FARGO BANK, NATIONAL ASSOCIATION, AS COLLATERAL AGENT
To: NEKTAR THERAPEUTICS
Reel/Frame 036866/0700 →
GRANT OF SECURITY INTEREST IN UNITED STATES PATENTS Recorded Oct 6, 2015
From: NEKTAR THERAPEUTICS
To: TC LENDING, LLC, AS COLLATERAL AGENT
Reel/Frame 036796/0562 →
GRANT OF SECURITY INTEREST Recorded Jul 17, 2012
From: NEKTAR THERAPEUTICS
To: WELLS FARGO BANK, NATIONAL ASSOCIATION, AS COLLATERAL AGENT
Reel/Frame 028571/0141 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 9, 2011
From: ZAPPE, HAROLD; BOSSARD, MARY J.
To: NEKTAR THERAPEUTICS
Reel/Frame 026881/0027 →